Thesis

191 Denosumab reduces lesional Fluoride skeletal burden on Na[18F]F PET-CT Figure 1. Box-and-whisker plots for the subcohorts of denosumab (n=8) and non-denosumab (n=7), the SUVcut-offs did not significantly change after treatment compared to baseline, p=0.237 and p=0.575 (Wilcoxon), respectively. 8

RkJQdWJsaXNoZXIy MjY0ODMw